Working… Menu
Trial record 14 of 23 for:    fenugreek

Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02789488
Recruitment Status : Completed
First Posted : June 3, 2016
Last Update Posted : June 3, 2016
Information provided by (Responsible Party):
Chemical Resources

Brief Summary:
Poly cystic ovary syndrome (PCOS) is a disease which is prevalent in women of reproductive age facing obesity along with increased risk of type-2 diabetes and high cholesterol levels. The genetically determined cause of the PCOS includes disturbed levels of insulin and androgens. Standardized fenugreek seed extract (Furocyst) contains compounds such as saponins & flavonoids which act on the insulin and indirectly helps to regulate the androgen levels in the body.

Condition or disease Intervention/treatment Phase
Poly Cystic Ovary Syndrome Dietary Supplement: Fenugreek seeds extract 500 mg Phase 4

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 50 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Efficacy and Safety of Furocyst in Patients With Poly Cystic Ovary Syndrome
Study Start Date : September 2013
Actual Primary Completion Date : July 2014
Actual Study Completion Date : July 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ovarian Cysts

Arm Intervention/treatment
Furocyst one caps BID
Dietary Supplement: Fenugreek seeds extract 500 mg
Furocyst one caps BID
Other Name: Furocyst

Primary Outcome Measures :
  1. Reduction in Ovary volume as assessed by ultrasound [ Time Frame: 12 weeks ]
    volume in cubic cms

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Premenopausal women between 18-45 years of age and BMI less than 42
  • Diagnosed with PCOS
  • Adequate hepatic, renal and hematological functions
  • Patients willing to give informed consent in writing

Exclusion Criteria:

  • Males
  • Post menopausal women
  • Women with hysterectomy
  • Patients with congenital adrenal hyperplasia
  • Patients suffering from Cushing's syndrome
  • Patients diagnosed with androgen secreting tumors
  • Patients with thyroid dysfunction (T3, T4 level is higher than that in normal women of reproductive age)
  • Patients with Hypo-gonadotropic and Hypo-gonadism (central origin of ovarian dysfunction)
  • Pregnancy or desire for pregnancy or lactating mothers

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02789488

Sponsors and Collaborators
Chemical Resources
Layout table for investigator information
Principal Investigator: Dr Amrita Sarkari Jaipuriar, MS Garg Hospital,Goalghar .Gorakhpur,UP,India

Layout table for additonal information
Responsible Party: Chemical Resources Identifier: NCT02789488     History of Changes
Other Study ID Numbers: CR001/PCOS-5-13
First Posted: June 3, 2016    Key Record Dates
Last Update Posted: June 3, 2016
Last Verified: September 2013
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Ovarian Cysts
Pathologic Processes
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases